HeyJaredMia Malan
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 9, 2026
- Outlet visibility, for TimesLive South Africa
- Top 50K sites
- Earliest in this view
- Jul 28, 2026
Latest articles
Meet 4 people who got the HIV prevention jab (opens the original)
Read excerpt
Almost 55,000 people in South Africa have already had a shot that protects them against HIV for six months at a time, the health department says. Lenacapavir, or LEN, has been available through the health department since June. The injection gives near-perfect protection against HIV and, because it lasts for six months, people only need to return to a clinic twice a year. For now, LEN is available at 360 government clinics — about one in 10 — across six provinces. The Free State, Limpopo and the
Aids is no longer exceptional. What happens now? (opens the original)
Read excerpt
Standing there, on a street corner in a famous favela, flanked by three policemen huddled together, speaking Portuguese, I realised the feeling was oddly familiar. My phone had just been stolen by two men passing by on a motorbike in one of Rio de Janeiro’s tourist hotspots. I was anxious, had no idea what was going to happen next and instantly felt guilty about taking the afternoon off. About 15km away, the 26th International Aids Conference had, for days, been filled with the same nagging unce
#Aids2026: three HIV announcements South Africa made in Rio (opens the original)
Read excerpt
South Africa returned from the 26th International Aids Conference in Rio de Janeiro last week with three big HIV announcements: By August 3 close to 36,000 HIV-negative people had taken LEN, according to health department figures — a quarter of them pregnant and breastfeeding women, a group that has a high risk of contracting HIV. Our team was on the ground and breaks down what the announcements could mean for the country’s HIV prevention programmes. Almost everyone who starts HIV prevention med
#Aids2026: Bhekisisa analysed SA’s first LEN roll-out data. Here’s what they found (opens the original)
Read excerpt
Just over half of everyone in Africa using the once-every-six-month HIV prevention injection, lenacapavir (LEN), through national roll-out programmes lives in South Africa. Health department data presented at South Africa’s exhibition booth at the International Aids Conference in Rio de Janeiro on Tuesday shows 31,297 of the continent’s roughly 60,000 LEN users are in South Africa. The health department started rolling out the jab at 360 government clinics — about 8% of South Africa’s public cli
#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters (opens the original)
Read excerpt
For the first time, a pharmaceutical company has given generic manufacturers permission to make copies of an HIV medicine before the studies proving it works have finished — with three of the seven licences awarded to African drug makers. This could bring the medicine — a once-a-month HIV prevention pill known as MK-8527, or alimatravir, made by Merck (known as MSD in South Africa) — to people much faster than previous drugs. That’s because the licences allow generic manufacturers to prepare the
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For TimesLive South Africa, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.